Fresenius SE+CO.KGAA O.N.

45.03 <%= Resources.Global.txtDown %>
Updated 18/07/2019
Change % -0.65% Stock price decreasing
Change -0.295 Stock price decreasing
Volume 1,865,915
High 45.70
Low 44.21
Open 45.50
ISIN DE0005785604
Prev close 45.33
# of shares 450.94M
Market cap 20,306M EUR

Market closed
Fresenius SE+CO.KGAA O.N.
Market is closed, opens at 08:00
Price development Latest 1 week 1 month 3 months 6 months 1 year
  45.03 -3.8% Stock price decreasing -6.6% Stock price decreasing -7.9% Stock price decreasing 4.9% Stock price increasing -35.2% Stock price decreasing
Powered by TradingView

Company profile

Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care, which accounted for 49% of consolidated revenue in 2018. The Kabi segment (20% of revenue) manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. At 27% of revenue, the Helios segment operates private hospitals primarily in Germany and Spain, and at 5% of revenue, Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
22 July 2019 00:52:23
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190703.1 - EUROWEB2 - 2019-07-22 01:52:23 - 2019-07-22 00:52:23 - 1000 - Website: OKAY